Revenue
2008
2009
2010
2011
2012
2013
2014
2015
2016
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.40B | $16.91B | $17.23B | $17.45B | $24.59B | $25.13B | $28.41B | $29.00B | $34.81B | $33.68B | $27.70B | $26.11B | $30.53B |
| Gross profit | $8.23B | $7.38B | $7.31B | $7.02B | $10.13B | $10.02B | $11.38B | $11.36B | $13.41B | $12.42B | — | — | — |
| Gross margin | 47.29% | 43.64% | 42.41% | 40.21% | 41.17% | 39.86% | 40.07% | 39.16% | 38.53% | 36.87% | — | — | — |
| Research & development | $1.47B | $1.40B | $1.34B | $1.22B | $1.64B | $1.90B | $1.96B | $2.04B | $2.12B | $1.96B | $1.60B | $1.38B | $1.39B |
| Operating expenses | $5.61B | $5.28B | $5.20B | $5.09B | — | — | $5.03B | $5.99B | $8.04B | $6.54B | — | — | $29.45B |
| Operating income | $2.62B | $2.10B | $2.11B | $1.93B | — | — | $6.36B | $5.37B | $5.37B | $5.88B | $4.61B | $3.34B | $1.08B |
| Operating margin | 15.05% | 12.40% | 12.25% | 11.05% | — | — | 22.38% | 18.52% | 15.42% | 17.46% | 16.65% | 12.79% | 3.55% |
| EBITDA | $3.07B | $2.73B | $2.54B | $2.73B | — | — | $7.97B | $6.97B | $7.08B | $7.44B | $5.99B | $4.84B | $2.53B |
| EBITDA margin | 17.65% | 16.18% | 14.73% | 15.63% | — | — | 28.07% | 24.04% | 20.34% | 22.09% | 21.64% | 18.55% | 8.28% |
| Net income | $1.09B | $907.0M | $735.0M | $1.15B | $2.51B | $1.95B | $3.63B | $4.85B | $2.75B | $3.56B | $3.03B | $1.75B | $2.01B |
| Net profit margin | 6.29% | 5.36% | 4.27% | 6.57% | 10.22% | 7.77% | 12.76% | 16.72% | 7.91% | 10.57% | 10.94% | 6.72% | 6.57% |
| Basic EPSper basic share | — | — | — | — | $2.87 | $2.17 | $3.95 | $5.22 | $2.94 | $3.82 | $3.32 | $1.93 | $2.21 |
| Diluted EPSper diluted share | — | — | — | — | $2.85 | $2.16 | $3.92 | $5.18 | $2.91 | $3.77 | $3.28 | $1.92 | $2.20 |
Reported shareholders